Division of Gastroenterology & Hepatology Research | NYU Langone Health

Division of Gastroenterology & Hepatology Research

We conduct research to better care for current and future patients with gastrointestinal and liver conditions.

Our research goals at NYU Langone’s Division of Gastroenterology and Hepatology are to provide access to the latest treatments in the pipeline to our patients and to advance knowledge of gastroenterology and hepatology through innovative basic science, translational research, and clinical trials. We aim to foster a spirit of scientific inquiry and innovation among faculty, fellows, and students.

Our researchers study the biology, prevention, diagnosis, and treatment of gastrointestinal (GI) and liver diseases. Among our current areas of research are the following:

  • role of the gut microbiome in health and the pathogenesis of disease such as colorectal cancer, liver cancer, and fatty liver and other diseases
  • role of GI infection and gut microbial dysbiosis in the pathogenesis of inflammatory bowel disease
  • quality and innovations in enhanced technologies for colon cancer screening
  • bariatric endoscopy outcomes in obesity and fatty liver disease
  • clinical trials in all areas of liver disease, inflammatory bowel disease, colorectal cancer screening and prevention, and other GI conditions
  • cirrhosis and hepatitis C infection

Select Faculty Publications

Esophageal Disorders in the Older Adult

Babbar, Shaili; Sachar, Moniyka; Faye, Adam; Knotts, Rita M

Current treatment options in gastroenterology. 2025 Dec ; 23:

Statin use for primary prevention of cardiovascular disease reduces the risk of incident IBD: A population-based cohort study

Faye, Adam S; Allin, Kristine H; Poulsen, Gry Juul; Jess, Tine

Journal of internal medicine. 2025 Oct 23;

Treatment-Free Outcomes Following Surgery for IBD: A Nationwide Cohort Study

Faye, Adam S; Axelrad, Jordan; Sun, Jiangwei; Halfvarsson, Jonas; ,; Myrelid, Par; Söderling, Jonas; Olén, Ola; Ludvigsson, Jonas F

Alimentary pharmacology & therapeutics. 2025 Oct 21;

Advancing Health Equity Through Telehealth: A Systematic Review and Meta-analysis of Remote vs. In-person Weight-loss Interventions among Black Women with Obesity

Farooque, Umar; Murtaza, Meer; Umer, Muhammad; Johar, Ayesha; Aparna, Fnu; Khan, Aqsa Riaz; Kumar, Anish; Ahmed, Nazeer; Qadri, Syeda Hafsa; Idrees, Hiba; Ullah, Aman; Aliyeva, Turkan; Shaukat, Aasma

Current obesity reports. 2025 Oct 20; 14:72

Mild Endoscopic Disease Activity Is Associated With Adverse Outcomes Among Older Adults With Inflammatory Bowel Disease

Tang, Catherine Z; Delau, Olivia R; Katz, Seymour; Axelrad, Jordan E; Hudesman, David; Shaukat, Aasma; Faye, Adam S

Alimentary pharmacology & therapeutics. 2025 Oct 15;

Circulating Tumor DNA-Based Blood Test for Colorectal Cancer Screening-Reply

Shaukat, Aasma; Levin, Theodore R

JAMA. 2025 Oct 08;

Comparative benefits, burdens and harms of emerging blood-based tests for colorectal cancer screening

Meester, Reinier G S; Piscitello, Andrew J; Duimstra, Joseph A; Liang, Peter S; Shaukat, Aasma; Levin, Theodore R

Journal of the National Cancer Institute. 2025 Oct 06;

Oral Bacterial and Fungal Microbiome and Subsequent Risk for Pancreatic Cancer

Meng, Yixuan; Wu, Feng; Kwak, Soyoung; Wang, Chan; Usyk, Mykhaylo; Freedman, Neal D; Huang, Wen-Yi; Um, Caroline Y; Gonda, Tamas A; Oberstein, Paul E; Li, Huilin; Hayes, Richard B; Ahn, Jiyoung

JAMA oncology. 2025 Sep 18;